Last updated on November 2017

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

---

Brief description of study

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

Detailed Study Description

24-Week trial comparing treatment with Study Medicine vs. placebo.

Patient Inclusion Criteria:

• Age >/= 18
• Diagnosis of definite AS
• Active AS
• Inadequate response to treatment.

Patient Exclusion Criteria:

• Major Surgery within 8 weeks prior to screening
• Inflammatory Disease other than AS
• Treatment with Investigational Medication within 4 weeks
• Hepatitis B, C, or HIV